Solution-Focused Brief Therapy for Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to reduce stress and anxiety in young cancer survivors. It compares an online therapy called Solution-Focused Brief Therapy to the usual care, which includes support and an educational book. The goal is to determine if this therapy can better support mental health, helping survivors feel more hopeful and engaged in life. Ideal participants are between 15 and 39 years old, have had cancer, are experiencing emotional distress, and speak English fluently. As an unphased trial, this study offers a unique opportunity to contribute to innovative mental health solutions for young cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on therapy for psychological distress, so it's best to discuss your medications with the trial coordinators.
What prior data suggests that Solution-Focused Brief Therapy is safe for adolescent and young adult cancer survivors?
Research has shown that Solution-Focused Brief Therapy (SFBT) produces positive results for various issues and groups, with no evidence of harm. Studies have found that SFBT effectively reduces depression and stress in breast cancer patients and significantly lowers anxiety in young cancer survivors. Designed to be hopeful and brief, this therapy focuses on the specific needs of young cancer survivors. To date, no reports of harmful effects from SFBT have emerged, making it a well-tolerated option for managing emotional distress.12345
Why are researchers excited about this trial?
Researchers are excited about Solution-Focused Brief Therapy (SFBT) for cancer survivors because it offers a fresh approach to emotional support by focusing on solutions rather than problems. Unlike traditional therapies that might delve into the emotional difficulties of living with cancer, SFBT emphasizes building on personal strengths and envisioning a positive future. This therapy is delivered virtually, making it more accessible and convenient for patients who may have mobility issues or live far from treatment centers. Additionally, the brief nature of the therapy—consisting of short, weekly sessions—can make it easier for patients to incorporate into their busy lives, potentially leading to quicker emotional relief and empowerment.
What evidence suggests that Solution-Focused Brief Therapy might be an effective treatment for psychological distress in cancer survivors?
Research has shown that Solution-Focused Brief Therapy (SFBT), which participants in this trial may receive, can help reduce mental distress, such as depression and stress, in cancer patients. One study found that SFBT significantly reduced cancer-related tiredness in breast cancer survivors. Additionally, SFBT has shown positive results in 86.3% of studies across various situations, with no evidence of harm. Another study demonstrated that SFBT effectively lowered depression and stress in breast cancer patients. These findings suggest that SFBT could be beneficial for young cancer survivors dealing with mental distress.12346
Who Is on the Research Team?
Anao Zhang
Principal Investigator
University of Michigan Rogel Cancer Center
Are You a Good Fit for This Trial?
This trial is for adolescent and young adult cancer survivors experiencing psychological distress. Participants should be dealing with the long-term impacts of cancer on their lives, such as challenges in education, employment, finances, sexual health, and relationships.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo virtual SFBT sessions or receive eTAU over 4-8 weeks
Follow-up
Participants are monitored for psychological distress and quality of life improvements post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Solution-Focused Brief Therapy
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan Rogel Cancer Center
Lead Sponsor
Children's Cancer Research Fund
Collaborator
Children's Cancer Research Fund
Collaborator